ReviewEuropean journal of clinical nutrition2013
Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?
Review in European journal of clinical nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials.European journal of clinical nutrition · 2017Pooled it
- Addition of Exercise Increases Plasma Adiponectin and Release from Adipose Tissue.Medicine and science in sports and exercise · 2015Trial
- Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin.BMJ open diabetes research & care · 2026Article
- Role of the Genetic Variants of Fetuin-A and Adiponectin in Type 2 Diabetes Mellitus: A Narrative Review.Cureus · 2025Review
- Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin.Frontiers in endocrinology · 2025Article
- Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity?Journal of clinical medicine · 2022Article
- Relationship between Adipose Tissue Derived Hormones and Cardiometabolic Risk according to Obesity Status.Clinical nutrition research · 2021Article
- Serum Adiponectin Levels and Their Association With Cardiometabolic Risk Factors in Patients With Psoriasis.Cureus · 2020Article
- Hypothalamic POMC deficiency increases circulating adiponectin despite obesity.Molecular metabolism · 2020Article
- Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease.Journal of clinical laboratory analysis · 2019Article
- Higher adiponectin concentrations are associated with reduced metabolic syndrome risk independently of weight status in Brazilian adolescents.Diabetology & metabolic syndrome · 2019Article
- Circulating PANDER concentration is associated with increased HbA1c and fasting blood glucose in Type 2 diabetic subjects.Journal of clinical & translational endocrinology · 2018Article
- Counting Footsteps with a Pedometer to Improve HMW Adiponectin and Metabolic Syndrome among Young Female Adults in the United Arab Emirates.Journal of obesity · 2018Article
- Postmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome.Healthcare (Basel, Switzerland) · 2016Article
- Plasma Adiponectin Levels in Elderly Patients with Prediabetes.Endocrinology and metabolism (Seoul, Korea) · 2015Article
- Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype.Journal of translational medicine · 2015Article
- Cut-off value of total adiponectin for managing risk of developing metabolic syndrome in male Japanese workers.PloS one · 2015Article
- Is the adiponectin-AMPK-mitochondrial axis involved in progression of nonalcoholic fatty liver disease?Hepatology (Baltimore, Md.) · 2014Article
- New insight into adiponectin role in obesity and obesity-related diseases.BioMed research international · 2014Review
- Adiponectin and metabolic syndrome: pathway on the relationship.European journal of clinical nutrition · 2013Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesThe pathogenesis of the metabolic syndrome (MetS) is not well understood. This review is based on the hypothesis that both traditional and emerging risk factors act through adiponectin. SUBJECTS AND
methodsWe conducted a search of the literature using prominent electronic databases and search terms that included in combination: adiponectin, diet, dietary patterns, exercise, metabolic rate, MetS and testosterone. Articles were restricted to studies conducted on adult humans, reported in English and within the time period 2000-2012. RESULTS AND
conclusionsBoth traditional and emerging risk factors associated with the MetS show some evidence of exerting their influence through adiponectin. High-quality randomized controlled trials that alter adiponectin levels are required to further corroborate this hypothesis.
Indexed as
Identifiers
23361156What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.